You are viewing our old website. These pages are available whilst we move to our new website.
They are no longer updated and the information may be incorrect.
Please contact us if you can't find the information you require.
The Haemophilia Centre at the Kent and Canterbury Hospital have recruited the first 3 UK patients to the A-MORE Trial. The study which will involve approx. 300 patients in more than 80 sites in more than 20 countries across Europe and the Middle East, aims to evaluate the long-term effectiveness of Elocta on joint health. The study involves multi-disciplinary data collection involving haematologists, physiotherapists and nurses.
